Alithea bio
alithea-bio.com
Actively hiring
Oncology Therapeutics
Cell & Gene Therapy
Biotechnology
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
11-50
employees, estimated range
Backers
1
arise – Der Deep-Tech Accelerator
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
2019
Founded
Registers and programsofficial lists and records that name the company
| Legal entity | Alithea Biotechnology GmbH | its site |
Founders and leadersfrom filings, registers and the company's site
Fanny Alicia GiannouVertreten durchcompany's site
Backed byfrom the funds' portfolios and accelerator catalogs
arise – Der Deep-Tech Accelerator Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Actym Therapeutics is deploying its biologically brilliant bacteria drug delivery platform to treat cancer with powerful immunotherapies…
Cancer immunotherapy that turns cancer cells into biofactories minting their own destruction.
Adventris Pharmaceuticals is a biotechnology company focusing on cancer immunotherapy.
Umoja Biopharma pioneering immunotherapy by reprogramming T cells in vivo to target cancer cells and generate lasting remission.
At Strike Pharma we are shaping a new era of immunotherapy by using our ADAC technology.
Unleashing unconventional antigens for cancer immunotherapy. Learn about our technology.
News
Alithea Bio
The Nature Index tracks the affiliations of scientific articles from high-quality publications. The research profile for Alithea Bio reflects the research output of authors from Alithea Bio who published articles in the 145 journals included in the Nature
Read more
Report
People
Fanny Alicia Giannou
Vertreten durch
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data